As of January 2025, Marksans Pharma has a market cap of $1.54B. This makes Marksans Pharma the world's 5978th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $849.79M | 0.56% |
2023 | $845.07M | 176.57% |
2022 | $305.56M | -3.16% |
2021 | $315.53M | -0.82% |
2020 | $318.15M | 263.17% |
2019 | $87.60M | -40.04% |
2018 | $146.09M | -30.29% |
2017 | $209.56M | 0.25% |
2016 | $209.04M | -61.94% |
2015 | $549.22M | 70.38% |
2014 | $322.34M | 249.15% |
2013 | $92.32M | 417.65% |
2012 | $17.84M | 100.00% |
2011 | $8.92M | -54.05% |
2010 | $19.41M | -35.09% |
2009 | $29.90M | -21.92% |
2008 | $38.29M | -76.51% |
2007 | $163.01M | 188.13% |
2006 | $56.57M | -48.66% |
2005 | $110.18M | 15.35% |
2004 | $95.52M | 247.19% |
2003 | $27.51M | 118.54% |
2002 | $12.59M | - |